Black Diamond Therapeutics (BDTX) Price to Earnings (2020 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Price to Earnings came in at 9.54 in Q2 2026, up 16.77% on a YoY basis from 8.17 in Q2 2025, and up 19.96% quarter-over-quarter from 11.92 in Q1 2026.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) Price to Earnings (2020 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has reported Price to Earnings for 7 consecutive years, with 9.54 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Earnings rose 16.77% year-over-year to 9.54; the trailing twelve-month figure through Jun 2026 stood at 2.23 (down 111.86% YoY), and the FY2025 full-year result was 8.37, up 629.08% from the prior year.
- Price to Earnings grew to 9.54 in Q2 2026 per BDTX's latest filing, from 11.92 in the prior quarter.
- Across five years, Price to Earnings topped out at 1.59 in Q1 2025 and bottomed at 21.99 in Q3 2025.
- Historically, Price to Earnings has averaged 8.24 across 5 years, with a median of 7.76 in 2025.
- The sharpest annual moves came in 2025 and 2026: Price to Earnings surged 111.73% in 2025, then tumbled 848.22% in 2026.
- Over 5 years, Price to Earnings stood at 3.1 in 2022, then plunged by 128.23% to 7.07 in 2023, then climbed by 3.17% to 6.84 in 2024, then dropped by 23.49% to 8.45 in 2025, then fell by 12.91% to 9.54 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 9.54, 11.92, and 8.45 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Black Diamond Therapeutics | 111.58 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.54 |
| Mar 31, 2026 | -11.92 |
| Dec 31, 2025 | -8.45 |
| Sep 30, 2025 | -21.99 |
| Jun 30, 2025 | -11.47 |
| Mar 31, 2025 | 1.59 |
| Dec 31, 2024 | -6.84 |
| Sep 30, 2024 | -13.96 |
| Jun 30, 2024 | -12.13 |
| Mar 31, 2024 | -13.58 |
| Dec 31, 2023 | -7.07 |
| Sep 30, 2023 | -6.29 |
| Jun 30, 2023 | -9.46 |
| Mar 31, 2023 | -3.30 |
| Dec 31, 2022 | -3.10 |
| Sep 30, 2022 | -2.85 |
| Jun 30, 2022 | -3.92 |
| Mar 31, 2022 | -3.98 |
| Dec 31, 2021 | -7.58 |
| Sep 30, 2021 | -8.86 |